BioSpace News Archive

Prostate cancer is the most common form of cancer among Canadian men and the third leading cause of cancer death.

Cullgen Inc., today announced that Mark Deeg, M.D., Ph.D., has joined the company as Executive Vice President of Clinical Development.

Novan, Inc. today announced positive preclinical results with berdazimer sodium in a SARS-CoV-2 transmission model in golden Syrian hamsters.

Tenax Therapeutics Set to Join Russell Microcap ® Index.

Purdue Pharma L.P. (“Purdue”) announced that FDA has accepted and granted priority review to the company’s Abbreviated New Drug Application for the vial dosage form of nalmefene hydrochloride injection.

ScienceMedia has tackled one of the biggest challenges facing decentralized trials – high staff turnover rates.

Longhorn Vaccines & Diagnostics announced today that it has been selected to deliver a presentation on the past success and future opportunities for its lead product, PrimeStore MTM.

Axiom Real-Time Metrics (“Axiom”), premier provider of unified eClinical solutions and services focused on small-to-medium life science organizations, will be exhibiting at BIO Digital 2021, the world’s largest virtual biotech partnering and education event.

TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today announced that the U.S. Food and Drug Administration (“FDA”) has announced the scheduling of a public advisory committee meeting

Cardiff Oncology, Inc. today announced the appointments of Mani Mohindru, Ph.D., and Renee P. Tannenbaum, Pharm.D., as independent members of the Company’s Board of Directors.